Clinical Trials in North Carolina

Showing 12621-12640 of 20,428 trials

A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients

NCT02374671

The purpose of this study is to evaluate the safety and effectiveness of the VisAbility Micro Insert System for the improvement of near visual acuity in presbyopic patients.

Presbyopia

Refocus Group, Inc.365 participantsStarted Nov 2014

Orange, California, United States • San Diego, California, United States • Honolulu, Hawaii, United States +11 more locations

COMPLETEDPhase 141 miles

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

NCT03109379

The purpose of this study is to determine if TAR-302-5018, an investigational drug-delivery system, is safe and tolerable in patients with idiopathic overactive bladder and urinary incontinence.

Idiopathic Overactive Bladder With Urinary Incontinence

Taris Biomedical LLC43 participantsStarted Apr 2017

Tucson, Arizona, United States • San Diego, California, United States • Pompano Beach, Florida, United States +9 more locations

A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Find Trials by Condition in North Carolina

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

MaxAn Post Market Surveillance Validation

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

Safety of PDT-Photofrin® Prior to Lung Surgery

Answer ALS: Individualized Initiative for ALS Discovery

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Radiesse® Safety Study For the Treatment of Hands

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade

Performance Assessment of a Modified Daily Disposable Contact Lens

A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia